全文获取类型
收费全文 | 214篇 |
免费 | 4篇 |
专业分类
儿科学 | 2篇 |
基础医学 | 16篇 |
临床医学 | 5篇 |
内科学 | 53篇 |
皮肤病学 | 4篇 |
神经病学 | 30篇 |
特种医学 | 4篇 |
外科学 | 45篇 |
预防医学 | 1篇 |
眼科学 | 1篇 |
药学 | 1篇 |
肿瘤学 | 56篇 |
出版年
2022年 | 3篇 |
2021年 | 1篇 |
2019年 | 5篇 |
2018年 | 3篇 |
2017年 | 1篇 |
2016年 | 3篇 |
2015年 | 1篇 |
2014年 | 3篇 |
2013年 | 3篇 |
2012年 | 7篇 |
2011年 | 3篇 |
2010年 | 9篇 |
2009年 | 6篇 |
2008年 | 6篇 |
2007年 | 9篇 |
2006年 | 7篇 |
2005年 | 10篇 |
2004年 | 8篇 |
2003年 | 8篇 |
2002年 | 7篇 |
2001年 | 7篇 |
2000年 | 9篇 |
1999年 | 8篇 |
1998年 | 3篇 |
1997年 | 2篇 |
1996年 | 2篇 |
1994年 | 6篇 |
1993年 | 1篇 |
1992年 | 6篇 |
1991年 | 9篇 |
1990年 | 8篇 |
1989年 | 10篇 |
1988年 | 12篇 |
1987年 | 13篇 |
1986年 | 8篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1970年 | 4篇 |
1969年 | 2篇 |
1966年 | 1篇 |
1965年 | 1篇 |
排序方式: 共有218条查询结果,搜索用时 15 毫秒
101.
102.
103.
Thuret G Manissolle C Campos-Guyotat L Guyotat D Gain P 《Investigative ophthalmology & visual science》2005,46(3):816-822
PURPOSE: Eliminating fetal calf serum (FCS) from corneal organ culture (OC) media has long been a challenge. This study was an assessment of a new animal compound-free (ACF) medium for corneal storage and of its combination with poloxamer for end-of-storage corneal deswelling. METHODS: A randomized controlled study with masked assessment compared the ACF medium to standard commercialized media containing 2% FCS and their combination with dextran for deswelling. Paired human corneas were randomly allocated at procurement, one to the ACF medium and the other to the FCS media, and then assessed at day (D)2 and D30 of OC storage and after 48 hours of deswelling. Comparison criteria were endothelial cell density (ECD) and morphometry by a corneal analyser, quality of endothelial visualization (using saline), EC mortality (trypan blue), corneal thickness, corneal transparency, and folding. Fifty-six corneas (28 pairs) with ECD of 2000 cells/mm(2) or more were enrolled. Data were compared using paired tests with P < 0.01 deemed significant. RESULTS: Parameters were similar at baseline (D2) between groups. Daily EC loss during the 30 days of storage was reduced with the ACF compared with standard (-0.31% +/- 0.30% vs. -0.88% +/- 0.38%, P < 0.001). With poloxamer 188 (Lutrol F68; BASF, Ludwigshafen, Germany), EC loss was substantially reduced (-1.43% +/- 3.60 vs. -15.41% +/- 10.13%, P < 0.001) and morphometry better preserved, despite thickness reduction, transparency improvement and folding reduction comparable to dextran. After 30 days of storage in ACF medium and deswelling in poloxamer 188, ECD was 30% higher (2466 +/- 447 cells/mm(2) vs. 1729 +/- 281 cells/mm(2), P < 0.001). ACF medium alone and combined with poloxamer 188 considerably facilitated EC visualization at D30 and after deswelling. CONCLUSIONS: The ACF medium combined with poloxamer 188 for deswelling showed superiority over standard FCS medium in its ability to preserve EC viability and facilitate endothelial visualization. This innovative use of poloxamer for deswelling appears far less toxic than does dextran. 相似文献
104.
Current trends in the management of glioblastoma in a French University Hospital and associated direct costs 下载免费PDF全文
105.
Expression of heat-shock proteins is associated with major adverse prognostic factors in acute myeloid leukemia 总被引:6,自引:0,他引:6
Thomas X Campos L Mounier C Cornillon J Flandrin P Le QH Piselli S Guyotat D 《Leukemia research》2005,29(9):1049-1058
To identify prognostic factors alternative or additional to drug-resistance and apoptosis proteins, we studied the impact of the expression of heat-shock proteins (HSPs) in 98 newly diagnosed acute myeloid leukemia (AML). HSP27 was expressed by 39%, HSP60 by 26%, HSP70 by 58%, HSP90 by 41%, and HSP110 by 30% of cases. HSP expressions were correlated with that of differentiation antigens (CD34, CD14, CD15, CD33) and that of drug-resistance (MRP, MRK) and apoptosis (Bcl-2) proteins. HSP90 and HSP110 were correlated with FAB subtype and karyotypic grouping. Complete remission (CR) was obtained in 68 cases (69%). Median disease-free survival (DFS) of the 68 remitters was 18.1 months with a 3-year DFS rate of 41%. CR rates were higher in patients with lower expression of HSPs. Overall survival (OS) was significantly longer in patients with lower expression of HSPs. Cytogenetics, CD34 positive expression, MRK positive expression, and HSP110 positive expression remained as pejorative prognostic factors for OS in the multivariate analysis. When considering patients with intermediate risk cytogenetics, HSP110 and MRP positive expressions and CD33 negative expression were of poor outcome, while HSP27 and HSP60 positive expressions appeared of pejorative prognostic value in patients with unfavorable karyotypes. 相似文献
106.
Martine Ffrench Anne Marie Manel Jean Pierre Magaud Denis Fiere Patrice Adeleine Denis Guyotat Paul André Bryon 《British journal of haematology》1987,65(4):419-423
Flow cytometry with propidium iodide and fluorescein isothiocyanate was used to study 46 cases of adult acute lymphoid leukaemia (ALL) before any form of chemotherapy. Cell proliferation was related to the other clinical and biological characteristics and its prognostic significance was evaluated. The following cell-cycle variables were determined: S, G2 + M, and the Low Protein Content fraction of G1 (LPC fraction). The L3 group, corresponding to B-ALL, had significantly higher proliferation than L1 and L2 (P less than 0.01). The proliferation rate was not significantly higher for T-ALL than for the other phenotypes. Complete remission was successfully induced significantly more often in cases with the LPC fraction under 50% (P less than 0.05). Failure was mainly related to resistance to chemotherapy. Of the four patients who died during aplasia, three had an LPC fraction below 25%. Duration of complete remission and survival were significantly shorter for L3 which is the most proliferative ALL (P less than 0.01). Survival was also found to be longer (P less than 0.05) when G2 + M was between 3.8% and 5.1%. This finding and the negative correlation between S and G2 + M (P less than 0.01) are discussed. 相似文献
107.
Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors 总被引:4,自引:5,他引:4
Rollin N Guyotat J Streichenberger N Honnorat J Tran Minh VA Cotton F 《Neuroradiology》2006,48(3):150-159
Advanced magnetic resonance (MR) imaging techniques provide physiologic information that complements the anatomic information
available from conventional MR imaging. We evaluated the roles of diffusion and perfusion imaging for the assessment of grade
and type of histologically proven intraaxial brain tumors. A total of 28 patients with intraaxial brain tumors underwent conventional
MR imaging (T2- and T1-weighted sequences after gadobenate dimeglumine injection), diffusion imaging and T2*-weighted echo-planar
perfusion imaging. Examinations were performed on 19 patients during initial diagnosis and on nine patients during follow-up
therapy. Determinations of relative cerebral blood volume (rCBV) and apparent diffusion coefficient (ADC) were performed in
the solid parts of each tumor, peritumoral region and contralateral white matter. For gliomas, rCBV values were greater in
high-grade than in low-grade tumors (3.87±1.94 versus 1.30±0.42) at the time of initial diagnosis. rCBV values were increased
in all recurrent tumors, except in one patient who presented with a combination of recurrent glioblastoma and massive radionecrosis
on histology. Low-grade gliomas had low rCBV even in the presence of contrast medium enhancement. Differentiation between
high- and low-grade gliomas was not possible using diffusion-weighted images and ADC values alone. In the peritumoral areas
of untreated high-grade gliomas and metastases, the mean rCBV values were higher for high-grade gliomas (1.7±0.37) than for
metastases (0.54±0.18) while the mean ADC values were higher for metastases. The rCBV values of four lymphomas were low and
the signal intensity–time curves revealed a significant increase in signal intensity after the first pass of gadobenate dimeglumine.
Diffusion and perfusion imaging, even with relatively short imaging and data processing times, provide important information
for lesion characterization. 相似文献
108.
P. Berthelot P. Loulergue H. Raberin M. Turco C. Mounier R. Tran Manh Sung F. Lucht B. Pozzetto D. Guyotat 《Clinical microbiology and infection》2006,12(8):738-744
This study evaluated a multidisciplinary strategy to decrease the rate of invasive pulmonary aspergillosis (IPA) among adult patients hospitalised in two haematology wards in a single 560-bed building at the University Hospital of Saint-Etienne. Upgrading of the air filtration system and construction of an air-lock chamber at the entrance to the unit were completed during 1994. In 1995, specific hygienic measures were introduced during hospital building work, including the use of plastic barriers, watering during demolition work, reduction of pedestrian traffic in construction areas, and the wearing of high-efficiency filtration masks by immunosuppressed patients when outside the protected unit. This strategy was evaluated by a prospective survey of IPA cases between 1993 and 2001, coupled with environmental surveillance. The number and risk-level of hospital renovation projects increased between 1995 and 2001 (p < 0.01). In parallel, the rate of IPA decreased globally in the haematology unit from 0.85% (1.19/1,000 patients) in 1993 to 0.28% (0.21/1,000 patients) in 2001. The incidence of IPA decreased significantly between 1993-1996 and 1997-2001 (p 0.02, Mann-Whitney test). These results show that a multidisciplinary approach involving engineers, infection control practitioners, mycologists and clinicians enables IPA rates among patients hospitalised in haematology wards to be significantly decreased. 相似文献
109.
C Dumontet J Jaubert C Sebban F Bouafia C Ardiet B Tranchand E Berger C Lucas D Guyotat B Coiffier 《Annals of oncology》2003,14(4):615-622
BACKGROUND: Patients with relapsing or refractory multiple myeloma have poor prognosis. Few compounds are active in these patients and response duration remains short. We report the results of an open phase II trial evaluating the efficacy and safety of fotemustine monotherapy. PATIENTS AND METHODS: Twenty-one patients with relapsing (17) or refractory (four) multiple myeloma received fotemustine 100 mg/m(2) on an outpatient basis on days 1 and 8 of the induction cycle, followed after a 6-week rest period by fotemustine 100 mg/m(2) every 3 weeks until progression or unacceptable toxicity. Fotemustine pharmacokinetics during the first day of induction was compared between patients with normal or abnormal renal function. RESULTS: Five of 20 eligible patients had an objective response giving an intention-to-treat response rate of 25% [95% confidence interval (CI) 6% to 44%] and a 35.7% response rate (95% CI 11% to 61%) in the 14 patients having received at least four injections of fotemustine. The median time to objective response was 8.9 months. The median times to progression and survival were 13.8 and 23.1 months, respectively, with a 2-year survival rate of 49%. The main toxicity was myelosuppression with grade 3-4 neutropenia and thrombocytopenia in 66% and 71% of patients, respectively. There was one toxic death by sepsis after induction. The pharmacokinetic parameters in renal-impaired patients were not significantly different from those in patients with normal renal function with a similar incidence of grade 3-4 toxicity in both groups. CONCLUSIONS: Fotemustine as a single agent has definite activity in patients with relapsing or refractory multiple myeloma, with acceptable toxicity and can be administered at conventional doses in patients with mild or moderate renal impairment. 相似文献
110.
In order to assess the proliferative capacity of leukemic subpopulations and to know whether it can be related to the stage of maturation, the expression of two surface antigens identifying distinct steps of leukocyte differentiation (CD15 and CD34) was studied by flow cytometry in correlation with DNA content in 16 cases of acute myeloid leukemia (AML). The surface markers were studied by indirect immunofluorescence, using the monoclonal antibodies VIMD5 (anti-CD15) and MY10 (anti-CD34). The percentage of cells stained by each antibody and the intensity of staining were heterogeneous. Double-staining showed that a small percentage of cells coexpressed both antigens. A correlation was found between the percentage of cells stained by MY10 and the percentage of cells in S + G2 + M in the whole population (p less than 0.05). The percentage of cells in S + G2 + M was significantly higher in MY10-positive than in MY10-negative cells (p less than 0.005), and also higher in VIMD5-positive than in VIMD5-negative cells (p less than 0.005). In the 14 cases expressing both antigens, the percentage of cells in S + G2 + M was higher in VIMD5-positive than in MY10-positive cells (p less than 0.05), whereas there was no difference between VIMD5-negative and MY10-negative cells. It is concluded that the phenotype heterogeneity observed in leukemic cell populations is associated with differences in proliferative capacities. The subset of leukemic cells with the more mature phenotype (CD15-positive) has the highest proliferative activity. 相似文献